Abstract: The present application relates to the field of pharmaceutical chemistry, and in particular, to a pyrrolopyrimidine compound represented by general formula (I), a stereoisomer thereof, or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for preparing the pyrrolopyrimidine compound represented by general formula (I), pharmaceutical compositions and an application of the pyrrolopyrimidine compound in treating diseases mediated by Janus Kinase.
Type:
Grant
Filed:
December 15, 2015
Date of Patent:
February 18, 2020
Assignees:
Centaurus Biophrama Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.
Inventors:
Li Zhu, Dengming Xiao, Yuandong Hu, Liguang Dai, Xiaowei Duan, Yinghui Sun, Yong Peng, Fansheng Kong, Hong Luo, Yongxin Han, Ling Yang, Shanchun Wang